Bio-Rad Laboratories manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials to identify, analyze and purify their components. Co. has two reportable segments: Life Science, which develops, manufactures and sells and services reagents, apparatus and instruments used for biological research; and Clinical Diagnostics, which designs, manufactures, sells and supports test and informatics systems, test kits and quality controls that serve clinical laboratories in the diagnostics market. Both segments operate worldwide. The BIO.B stock yearly return is shown above.
The yearly return on the BIO.B stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the BIO.B annual return calculation with any dividends reinvested as applicable (on ex-dates).
|